Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,844,420 | 8,819,686 | 7,362,431 | 14,066,280 | 3,142,720 |
| Depreciation Amortization | 5,186,382 | 3,603,312 | 3,964,568 | 4,208,233 | 8,346,240 |
| Income taxes - deferred | -1,049,831 | -608,981 | -421,184 | -244,452 | -1,963,360 |
| Accounts receivable | -429,673 | -818,647 | 218,874 | -153,068 | -517,440 |
| Accounts payable and accrued liabilities | 435,085 | 476,227 | 533,578 | 98,238 | 189,280 |
| Other Working Capital | 826,877 | -449,887 | 1,599,551 | -1,183,423 | -469,280 |
| Other Operating Activity | 288,970 | 68,480 | -809,238 | -8,282,814 | -54,880 |
| Operating Cash Flow | $11,102,230 | $11,090,190 | $12,448,580 | $8,508,993 | $8,673,280 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -80,451 | -129,080 | -105,280 |
| PPE Investments | -2,174,341 | -751,217 | -1,567,607 | -1,366,191 | -663,040 |
| Net Acquisitions | N/A | N/A | N/A | 11,845,650 | N/A |
| Purchase Of Investment | -4,333,529 | -1,559,328 | -6,986,206 | -6,251,808 | -589,120 |
| Sale Of Investment | 45,457 | 141,182 | N/A | N/A | N/A |
| Other Investing Activity | -247,847 | -16,858 | 0 | 1 | 0 |
| Investing Cash Flow | $-6,710,260 | $-2,186,220 | $-8,634,264 | $4,098,572 | $-1,357,440 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 827,960 | 226,524 | -489,803 | 322,129 | -172,480 |
| Debt Issued | 51,950 | 1,632,026 | N/A | 2,306,304 | 2,236,640 |
| Debt Repayment | -3,987,193 | -2,863,685 | -2,651,327 | -4,514,370 | -2,315,040 |
| Common Stock Issued | 211,049 | 198,077 | 220,057 | 231,887 | 181,440 |
| Common Stock Repurchased | -641,804 | -523,639 | -451,944 | -938,971 | -10,080 |
| Dividend Paid | -4,886,584 | -4,495,711 | -4,798,653 | -4,547,496 | -4,309,760 |
| Other Financing Activity | -290,058 | -306,597 | -176,282 | -267,298 | -306,880 |
| Financing Cash Flow | $-8,714,680 | $-6,133,005 | $-8,347,953 | $-7,407,815 | $-4,696,160 |
| Exchange Rate Effect | -34,634 | 8,429 | 17,747 | -73,107 | 10,080 |
| Beginning Cash Position | 13,784,170 | 10,639,250 | 16,462,840 | 10,768,460 | 7,756,000 |
| End Cash Position | 9,426,833 | 13,418,650 | 11,946,940 | 15,895,100 | 10,558,240 |
| Net Cash Flow | $-4,357,340 | $2,779,397 | $-4,515,893 | $5,126,643 | $2,802,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,102,230 | 11,090,190 | 12,448,580 | 8,508,993 | 8,673,280 |
| Capital Expenditure | -3,272,875 | -2,318,974 | -2,417,073 | -2,414,822 | -2,033,920 |
| Free Cash Flow | 7,829,355 | 8,771,216 | 10,031,507 | 6,094,171 | 6,639,360 |